Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management

Bhagwan Singh Meena; Mahesh Kumar; Shubhangi Anand Kale

doi:10.5455/njppp.2023.13.12597202220122022

2024, Vol: 14, Issue: 10

14 / 10Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

NJPPP Manuscript Submission Form

« Previous Article

Original Research
Online Published: 27 Dec 2022

Natl J Physiol Pharm Pharmacol. 2023; 13(2): 367-369

doi: 10.5455/njppp.2023.13.12597202220122022

Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management

Bhagwan Singh Meena, Mahesh Kumar, Shubhangi Anand Kale.

Abstract
Background: The prevalence of chronic renal failure has increased, as has the need for renal replacement therapy, as both diabetes and hypertension have become more prevalent. Patients’ mortality rates from cardiac causes have increased despite effective monitoring and care. Dyslipidemia significantly contributes to the risk of arteriosclerotic cardiovascular disease, the main cause of death in people with chronic kidney disease (CKD).

Aims and Objectives: The objectives of this study were to measurement of hyperlipidemia in patients with CKD on hemodialysis/conservative management.

Materials and Methods: The investigation was conducted on 250 patients with CKD at all stages who were receiving hemodialysis and conservative of both sexes aged 20 years or more and sex-matched healthy control subjects. Lipid profiles of each subject were measured in specimens.

Results: In our study, dyslipidemia was identified as having high levels of total cholesterol, triglycerides, and low-density lipoprotein and low levels of high-density lipoprotein.

Conclusion: The significance of dyslipidemia as a standalone risk factor for coronary artery disease (CAD) in CKD patients was examined in this study. Hence, based on the evidence presented above, we conclude that close monitoring of the ideal cholesterol levels in CKD patients is necessary to reduce the risk of CAD-related death. In CKD patients, monitoring and treating dyslipidemia can reduce mortality.

Key words: Chronic Kidney Disease; Hypertriglyceridemia; Lipid Profile; Dyslipidemia; Coronary Artery Disease

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Bhagwan Singh Meena Articles by Mahesh Kumar Articles by Shubhangi Anand Kale
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Meena BS, Kumar M, Kale SA. Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management. Natl J Physiol Pharm Pharmacol. 2023; 13(2): 367-369. doi:10.5455/njppp.2023.13.12597202220122022

Web Style

Meena BS, Kumar M, Kale SA. Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management. https://www.njppp.com/?mno=101443 [Access: November 02, 2024]. doi:10.5455/njppp.2023.13.12597202220122022

AMA (American Medical Association) Style

Meena BS, Kumar M, Kale SA. Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management. Natl J Physiol Pharm Pharmacol. 2023; 13(2): 367-369. doi:10.5455/njppp.2023.13.12597202220122022

Vancouver/ICMJE Style

Meena BS, Kumar M, Kale SA. Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management. Natl J Physiol Pharm Pharmacol. (2023), [cited November 02, 2024]; 13(2): 367-369. doi:10.5455/njppp.2023.13.12597202220122022

Harvard Style

Meena, B. S., Kumar, . M. & Kale, . S. A. (2023) Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management. Natl J Physiol Pharm Pharmacol, 13 (2), 367-369. doi:10.5455/njppp.2023.13.12597202220122022

Turabian Style

Meena, Bhagwan Singh, Mahesh Kumar, and Shubhangi Anand Kale. 2023. Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management. National Journal of Physiology, Pharmacy and Pharmacology, 13 (2), 367-369. doi:10.5455/njppp.2023.13.12597202220122022

Chicago Style

Meena, Bhagwan Singh, Mahesh Kumar, and Shubhangi Anand Kale. "Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management." National Journal of Physiology, Pharmacy and Pharmacology 13 (2023), 367-369. doi:10.5455/njppp.2023.13.12597202220122022

MLA (The Modern Language Association) Style

Meena, Bhagwan Singh, Mahesh Kumar, and Shubhangi Anand Kale. "Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management." National Journal of Physiology, Pharmacy and Pharmacology 13.2 (2023), 367-369. Print. doi:10.5455/njppp.2023.13.12597202220122022

APA (American Psychological Association) Style

Meena, B. S., Kumar, . M. & Kale, . S. A. (2023) Hyperlipidemia in patients with chronic kidney disease on hemodialysis/conservative management. National Journal of Physiology, Pharmacy and Pharmacology, 13 (2), 367-369. doi:10.5455/njppp.2023.13.12597202220122022

Author Login Reviewer Login About Publisher Editorial Policies Editorial Review Policy Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Digital Archiving & Preservation Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article